Compare
CJC-1295 vs GHK-Cu
Side-by-side observational reports from PeptIQ users. This compares self-reported patterns — not clinical head-to-head trials.
CJC-1295
Positive 96% · Neutral 4% · Negative 0%
Most reported benefits
Most reported side effects
Dose distribution
Median: 400–600 mcg · Most common: 200–400 mcg
Commonly stacked with
How repeat users are trending
Among repeat reporters, 92% said they felt similar to their last entry, 8% more positive, and 0% more negative.
Overall, repeat reporters leaned more positive than their previous entry.
Median gap between entries: 48 days · Based on 25 repeat reporters
GHK-Cu
Positive 3% · Neutral 97% · Negative 0%
Most reported benefits
Most reported side effects
Dose distribution
Median: 2000+ mcg · Most common: 2000+ mcg
Commonly stacked with
How repeat users are trending
Among repeat reporters, 89% said they felt similar to their last entry, 11% more positive, and 0% more negative.
Overall, repeat reporters leaned more positive than their previous entry.
Median gap between entries: 46 days · Based on 45 repeat reporters